NewsBeat: Microbicide Reduces Women's HIV Risk in Large-Scale Trial
By Lisa Rossi
Two large clinical trials have found that a microbicide prevention method can safely help reduce new HIV infections in women.
Results of the ASPIRE trial, which enrolled more than 2,600 women in Africa, were announced today at the Conference on Retroviruses and Opportunistic Infections in Boston. The results also will be published online in the New England Journal of Medicine.